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The putative risk/protective factors for several personality disorders remain unclear.
The vast majority of published studies has assessed personality characteristics/traits
rather than disorders. Thus, the current umbrella review of meta-analyses (MAs) aims
to systematically assess risk or protective factors associated with personality disorders.
We searched PubMed–MEDLINE/PsycInfo databases, up to August 31, 2020. Quality of
MAs was assessed with AMSTAR-2, while the credibility of evidence for each association
was assessed through standard quantitative criteria. Out of 571 initial references, five
meta-analyses met inclusion criteria, encompassing 56 associations of 26 potential
environmental factors for antisocial, dependent, borderline personality disorder, with a
median of five studies per association, and median 214 cases per association. Overall,
35 (62.5%) of the associations were nominally significant. Six associations met class II
(i.e., highly suggestive) evidence for borderline personality disorder, with large effect sizes
involving childhood emotional abuse (OR = 28.15, 95% CI 14.76–53.68), childhood
emotional neglect (OR = 22.86, 95% CI 11.55–45.22), childhood any adversities
(OR = 14.32, 95% CI 10.80–18.98), childhood physical abuse (OR = 9.30, 95% CI
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6.57–13.17), childhood sexual abuse (OR = 7.95, 95% CI 6.21–10.17), and childhood
physical neglect (OR= 5.73, 95%CI 3.21–10.21), plus 16 further associations supported
by class IV evidence. No risk factor for antisocial or dependent personality disorder was
supported by class I, II, and III, but six and seven met class IV evidence, respectively.
Quality of included meta-analyses was rated as moderate in two, critically low in three.
The large effect sizes found for a broad range of childhood adversities suggest that
prevention of personality disorders should target childhood-related risk factors. However,
larger cohort studies assessing multidimensional risk factors are needed in the field.
Keywords: umbrella review, personality disorder, prevention, meta-analysis, risk factor, systematic review,
psychiatry, mental health
INTRODUCTION
Personality disorders are defined as “an enduring pattern of
inner experience and behavior that deviates markedly from
the expectations of the individual’s culture, is pervasive and
inflexible, has an onset in adolescence or early adulthood, is stable
over time, and leads to distress or impairment.”
It has been reported that globally, personality disorders have
a prevalence around 3 to 10% in the global population (1), and
much higher in people affected by other mental disorders (2), and
so it is considered a global mental health priority (3). Their peak
age at onset is at age 20.5 years (4).
In the last 50 years, a lot of interest went into personality
disorders, promoting their status from an unreliable and not
so valid diagnosis before the 1960s, to a condition with clear
diagnostic criteria in particular after introduction of DSM-III (5).
Then, DSM-based criteria have raised criticism, and alternative
diagnostic frameworks have been proposed (1). They are now
classified differently in Diagnostic and Statistical Manual (DSM),
5th version (6) and in International Classification Diseases
(ICD)-11 (7). DSM-V classifies personality disorders in three
clusters (A, B, and C) and “other personality disorders.” Cluster
A includes paranoid personality disorder, schizoid personality
disorder, and schizotypal personality disorder; cluster B includes
antisocial personality disorder, borderline personality disorder,
histrionic personality disorder, and narcissistic personality
disorder; cluster C includes avoidant personality disorder,
dependent personality disorder, and obsessive-compulsive
personality disorder (6). ICD-11 applies a different approach,
with the aim to identify fewer categories, which overlap less and
ultimately have greater clinical utility (1). Specifically, ICD-11
categorizes personality disorders (6D10) into mild personality
disorder, moderate personality disorder, and severe personality
disorder, in addition to which Prominent personality traits
or patterns (6D11), namely, Negative affectivity, Detachment,
Dissociality, Disinhibition, Anankastic, or Borderline pattern in
personality disorder or difficulty, must be further specified (7).
Structural brain alterations, namely, bilateral gray matter
reductions in concentrations in ventral cingulate gyrus, medial
temporal lobe, and fronto-limbic structures, are associated with
different personality disorders defined according to several
versions of DSM (8–11). Beyond cross-sectional associations
with phenotypes and biomarkers, several risk factors for
personality disorders have also been described. An overview
of systematic reviews (12) focused on systematic reviews on
risk factors for personality disorders. However, it only focused
on parenting style, and it also focused on qualitative reviews
rather than quantitative meta-analyses (12). Also, evidence from
meta-analyses is frequently biased, and the credibility of the
claimed associations between putative risk or protective factors
for personality disorders remains unknown. To fill this gap
in the literature, we conducted an umbrella review focused
on environmental risk and protective factors for personality
disorders, to identify and measure possible methodological
limitations and sources of bias in the published and unpublished
evidence, which might have underestimated or inflated claimed
associations, as previously shown in several previous umbrella
reviews on risk factors for mental disorders or obesity (13–
17). Therefore, the aim of this umbrella review was to grade
the evidence from meta-analyses of cohort and case–control
studies on protective and risk factors for personality disorders
accounting for several sources of bias and applying established
quantitative criteria.
METHODS
This umbrella review adhered to state-of-the-art methods of
previously published or planned umbrella reviews (15, 18–23),
and according to the Meta-analysis of Observational Studies
in Epidemiology (MOOSE) and the Preferred Reporting Items
for Systematic Reviews and Meta-analyses (PRISMA) were
followed in conducting and reporting this umbrella review
(Supplementary Tables 1, 2) (24, 25). The study followed an a
priori protocol, available on request. MS, AFC, PF-P designed
the study, prepared the search key, and drafted the protocol.
ED run the statistical analyses. Four investigators (MS, ED,
AM, and PK, all MDs) divided into two couples independently
performed literature screening and data extraction, including
quality assessment of included meta-analyses.
Literature Search Strategy
We conducted a systematic search in PubMed and PsycINFO
from inception to August 31, 2020. We included meta-analyses
of case–control and cohort studies that assessed risk or protective
factors for personality disorders, defined according to ICD
or DSM, any version (6, 7, 26). The search strategy was
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“(personality disorder) AND meta-analysis.” No restrictions
regarding year of publication, language, country, ethnicity, or
any other characteristic were applied during the search process.
We also hand searched references of included meta-analyses and
other relevant articles. When authors did not agree regarding
screening or data extraction, a third author (MS) resolved any
conflict, reaching a consensus with the two authors.
Eligibility Criteria
We only included systematic reviews that also conducted a
quantitative meta-analysis pooling data from case–control or
cohort (either retrospective or prospective) studies reporting on
environmental factors that may affect the risk of the disorders of
interest, as per the ICD or DSM criteria. Specifically, we included
disorders that corresponded to ICD-10 “F60 Specific personality
disorders” (26) and “Personality disorder” in DSM-5 (6). Risk or
protective factors of interest were deemed eligible, regardless of
the direction of the association (protective or risk factor). No
language restriction was applied.
Meta-analyses of studies that included other-than-human
population, having a cross-sectional design, as well as
focusing on genome-wide associations or on single nucleotide
polymorphism were excluded. Also, systematic reviews without
a quantitative meta-analytic data synthesis, narrative reviews,
and commentaries/letters to the editor were not included in the
present umbrella review.
Finally, if multiple meta-analyses investigated the same risk
or protective factor and the same outcome, only the meta-
analysis with the largest number of studies pooled to measure the
association was retained.
Data Extraction
We extracted information into a standardized pre-defined
template. The list of variables of interest included PMID/DOI
of the included study, first author, year of publication, design
of included studies (cohort, case–control), number of included
studies in the meta-analysis, specific population cohort (i.e.,
general population, primary school, secondary school, university
students, hospital sample, or a sample with a specific somatic,
mental, or somatic/mental comorbid condition, etc.) as well
as the reference/comparison population (i.e., no risk factor in
cohort studies, no disorder in case–control studies), tools for the
definition of both population and risk/protective factor (DSM,
ICD, clinical records, rating scales), specific protective or risk
factor, outcome (ICD or DSM code if available, or definition of
specific disorders as reported by authors given inclusion criteria
were met), and its risk estimate. We assessed the methodological
quality of included meta-analyses as independent couples of two
investigators (JD, PK, AM, and MS, all MDs) by means of the
AMSTAR (A Measurement Tool to Assess Systematic Reviews)
version 2 (27). If needed, we contacted authors to ask for data.
Data Analysis
For each association (i.e., between each specific risk or protective
factor and personality disorder), we pooled effect sizes of
individual studies reported in each meta-analysis, as well as
cases developing personality disorder and total sample size,
and recalculated the pooled effect sizes with its 95% CIs,
using random-effects models (28). We transformed the effect
sizes or modified the direction of associations reported in
original publications only for the associations with continuous
or correlational data (e.g., Hedges g, beta coefficients) to present
comparable estimates (i.e., equivalent odds ratio—eOR) (22).
Heterogeneity wasmeasuredwith the I2 statistic (29). In addition,
95% prediction intervals for the effect sizes were computed
to estimate the possible range in which the effect sizes of
future studies were anticipated to fall (30). We also examined
small-study effect bias, testing whether smaller studies generated
larger effect sizes compared with larger studies (15, 18–22, 31).
Specifically, as indicators of small-study effect, we used both the
Egger regression asymmetry test (p ≤ 0.10) and whether the
random-effects summary effect size were larger than the effect
size of the largest study contributing to that association (18, 20,
21, 31). We finally measured the presence of excess significance
bias by assessing whether the observed number of studies with
nominally statistically significant results was different from the
expected number of studies with statistically significant results
(32, 33). The expected number of statistically significant studies
per association was calculated by summing the statistical power
estimates for each component study. The power estimates of
each component study depend on the plausible effect size for the
examined association, which we assumed to be the effect size of
the largest study (i.e., the smallest SE) per association (33). For
excess significance bias, a p ≤ 0.10 was considered statistically
significant (32). All analyses were conducted in Stata/MP, version
10.0 (StataCorp LLC).





1. More than 1,000 cases
2. Significant summary associations (p< 1
× 10−6) per random-effects calculations
3. No evidence of small-study effects
4. No evidence of excess of significance
bias
5. Prediction intervals not including the null
value
6. Largest study nominally significant (p <
0.05)
7. No large heterogeneity (i.e., I2 < 50%)
Highly suggestive evidence
(class II)
1. More than 1,000 cases
2. Significant summary associations (p< 1
× 10−6) per random-effects calculation




1. More than 1,000 cases
2. Significant summary associations (p <




1. All other associations with p ≤ 0.05
Non-significant associations (NS) 1. All associations with p > 0.05
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Assessment of the Credibility of Evidence,
and Sensitivity Analyses
In line with former umbrella reviews (14, 16, 17, 34). eligible
associations for personality disorders were classified into five
levels according to the strength of the evidence of potential
environmental risk/protective factors: convincing (class I), highly
suggestive (class II), suggestive (class III), weak (class IV), and not
significant (NS) (Table 1).




Out of 571 initial hits, 436 were assessed at title and abstract
level, and 415 were excluded. The remaining 21 were assessed
at full-text level, and 16 were excluded, ultimately including 5
meta-analyses. The list of excluded meta-analyses after full-text
assessment, with specific reason for exclusion, is reported in
online Supplementary Material. Finally, five meta-analyses were
included in this umbrella review (35–39) (Table 2). The study
selection flow is reported in Figure 1. The whole dataset with
results from individual studies is available on reasonable request.
Descriptive Results of the Included
Associations
The characteristics of included studies are described in Table 2.
The five eligible meta-analyses corresponded to 56 with available
data for synthesis, between 26 potential putative risk/protective
factors and 3 personality disorders (antisocial, borderline, and
dependent personality disorder) (Tables 2, 3). The eligible meta-
analyses were published between 1999 and 2020. The median
number of studies per association was 5 [interquartile range
(IQR) = 3–14]. The median number of cases per association
was 214 (IQR = 98–2,420) and the number of cases was >1,000
in 14 associations, while in 2 associations the number of cases
was not reported (Tables 3, 4). All eligible meta-analyses used
summary-level data from published literature. No protective
factors were identified.
Quality Assessment of Included Articles
Based on the AMSTAR2 assessment, two meta-analyses (40%)
met the moderate quality level and three (60%) were of low
quality (Table 2).
Summary of Associations
Thirty-five of the 56 analyzed associations (62.5%) presented a
statistically significant effect (p<0.05) under the random-effects
model, but only 12 (21.4%) reached p < 10−6. Twenty-five
associations (44.6%) presented a large heterogeneity (I2 > 50%),
while only for 13 associations (23.2%) the 95% prediction interval
did not include the null. In addition, the evidence for small-study
effects and excess significance bias was noted for 20 (35.7%) and
16 (28.5%) associations, respectively.
Associations for Antisocial Personality
Disorder
A total of 14 of the 56 associations examined associations for
antisocial personality disorder. Six of those presented a nominally
TABLE 2 | Characteristics of eligible articles.
References Number of
associations
Potential environmental risk/protective factor Personality disorder AMSTAR 2
quality
Fossati et al. (35) 21 Sexual abuse (overall; between age 0 and 6; between
age 13 and 18; by father; by mother; by sibling; by other
relatives; by non-relatives; by any caretaker; with use of
force; with disclosure; with help; with fondling; with
genital fondling; with oral sex; with penetration; longer
duration; higher severity; higher frequency; higher
number of perpetrators
Borderline personality disorder Critically low
Kane and
Bornstein (37)
5 Any childhood adversity; physical abuse; sexual abuse;
emotional abuse; neglect
Dependent personality disorder Critically low
Nottell (39) 25 Genetic risk/mental disorder; genetics; temperament; IQ;
disorders/pathology during childhood;
experiential/external factors; physical abuse; sexual
abuse; emotional abuse; separation and loss; poor
school; medical incidents; family socioeconomic status;
family dysfunction; interpersonal factors; neglect;
rejecting; unstable or erratic; inconsistent discipline;
harsh parenting; parent delinquency; delinquent sibling;
parent disorder/pathology; social desirability; behavioral
factors (child antisocial behavior)
Antisocial personality disorder Critically low
Porter et al. (36) 6 Any childhood adversity; physical abuse; sexual abuse;
emotional abuse; emotional neglect; physical neglect
Borderline personality disorder Moderate
Winsper et al.
(38)
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FIGURE 1 | PRISMA flow chart, last search August 31, 2020.
statistically significant effect (p ≤ 0.05) and met the class IV
evidence criteria while only 1 association reached p < 10−6.
None of those associations were supported by class I, II, and III
evidence. After excluding the criterion of 1,000 cases, one factor,
namely, disorders/pathology during childhood, was upgraded to
the class II evidence while two others, namely, psychobiological
factor and behavioral factor, were upgraded to the class III
evidence (Tables 3, 4).
Associations for Borderline Personality
Disorder
A total of 22 of the 56 associations examined associations for
borderline personality disorder. Twenty-two of those presented
a nominally statistically significant effect (p ≤ 0.05), while
nine of those associations reached p < 10−6. None of those
associations were supported by class I or III evidence (Table 3).
Six associations were supported by class II evidence (Table 3)































TABLE 3 | Potential significant environmental risk/protective factors of personality disorders.



























154/7,607 10 OR 4.10 (2.28, 2.76) 2.3 × 10−6 Yes 89.5 Yes/yes 4.10 IV III
Nottell (39) Disorders/pathology
during childhood
114/662 5 OR 12.82 (4.68, 35.11) 6.9×10−7 Yes 55.4 No/no 12.82 IV II
Nottell (39) Interpersonal
factor
965/4,280 17 OR 1.66 (1.16, 2.37) 0.006 Yes 76.4 No/NP 1.66 IV IV
Nottell (39) Rejecting 109/470 2 OR 2.11 (1.36, 3.27) 0.001 NA 0.00 NA/yes 2.11 IV IV
Nottell (39) Parent
disorder/pathology
537/2,086 9 OR 2.08 (1.26, 3.44) 0.004 Yes 73.4 No/no 2.08 IV IV
































3,072/36,449 20 OR 5.73 (3.21, 10.21) 3.4 × 10−9 Yes 93.4 No/yes 5.73 II II
Winsper et al.
(38)
Sexual abuse 231/660 9 d 0.70 (0.53, 0.87) 1.1 × 10−15 No 0.0 Yes/yes 3.20 IV IV
Winsper et al.
(38)





110/8,442 5 d 0.62 (0.46, 0.78) 8.9 × 10−15 No 11.7 No/NP 3.07 IV I
Winsper et al.
(38)


































































































TABLE 3 | Continued


























































































3,800/152,249 10 d 0.18 (0.01, 0.35) 0.040 Yes 46.7 No 1.38 IV IV
Kane and
Bornstein (37)
Physical abuse 6,309/36,023 5 d 0.29 (0.03, 0.56) 0.031 Yes 65.5 No 1.69 IV IV
Kane and
Bornstein (37)
Sexual abuse 3,854/35,623 7 d 0.42 (0.56, 0.68) 0.002 Yes 72.2 No 2.14 IV IV
Kane and
Bornstein (37)






111/1,066 4 d 0.43 (0.20, 0.20) 1.6 × 10−4 Yes 0.0 Yes 2.18 IV III
d, Cohen’s d; OR, odds ratio; PI, prediction interval; I2, heterogeneity; eOR, equivalent OR; NA, not applicable; NP, not permitted.


















































































TABLE 4 | Non-significant (p > 0.05) risk/protective factors for personality disorders.





















Nottell (39) Genetics 45/316 4 OR 2.55 (0.95, 6.82) 0.063 Yes 79.3 Yes/yes 2.55 NS
Nottell (39) Any childhood
adversity
581/26,693 17 OR 1.69 (0.93, 3.07) 0.082 Yes 83.2 No/no 1.69 NS
Nottell (39) Physical abuse 197/755 3 OR 1.32 (0.53, 2.61) 0.543 Yes 66.5 No/NP 1.32 NS
Nottell (39) Separation and
loss




79/24,316 3 OR 1.07 (0.44, 2.59) 0.881 Yes 62.1 Yes/no 1.07 NS
Nottell (39) Family
dysfunction
127/561 4 OR 1.49 (0.54, 4.11) 0.444 Yes 78.5 No/NP 1.49 NS
Nottell (39) Neglect in
childhood
186/1,129 3 OR 1.40 (0.73, 2.68) 0.308 Yes 66.3 Yes/yes 1.40 NS
Nottell (39) Inconsistent
discipline
























with use of force






























































































































































































































































































































































































































































































































































































































































































involving childhood emotional abuse, childhood emotional
neglect, childhood any adversities, childhood physical abuse,
childhood sexual abuse, and childhood physical neglect. Sixteen
other associations were supported by class IV evidence (Table 3)
and 12 were non-significant (Table 4). After excluding the
criterion of 1,000 cases, all factors with class II evidence remained
at the same level while two others, namely, sexual abuse
overall and sexual abuse by non-relatives, were upgraded to the
class III evidence.
Associations for Dependent Personality
Disorder
A total of 8 of the 56 associations examined associations for
dependent personality disorder. Seven of those presented a
nominally statistically significant effect (p ≤ 0.05) and met the
class IV evidence criteria while only two associations reached p
< 10−6. None of those associations were supported by class I, II,
and III evidence. After excluding the criterion of 1,000 cases, two
factors, namely, any childhood maltreatment and any childhood
abuse in other clinical populations, were upgraded to the class
II evidence, while another one, namely, any childhood abuse
vs. no childhood abuse, was upgraded to the class III evidence
(Tables 3, 4).
DISCUSSION
This is the first umbrella review pooling data from five meta-
analyses on risk factors for personality disorders. Findings
show that out of 56 associations between 26 potential
environmental factors and antisocial, dependent, borderline
personality disorder, despite 35 (62.5%) of the associations were
nominally significant, only 6 (8.92%) associations met class II
evidence for borderline personality disorder, involving childhood
emotional abuse, childhood emotional neglect, childhood any
adversities, childhood physical abuse, childhood sexual abuse,
and childhood physical neglect. All other significant associations
were classified as weak (class IV evidence).
These results likely reflect the epidemiological distribution
of borderline personality disorders, which represents the most
common personality disorders both in clinical populations
(36) and in the young general population, with a lifetime
prevalence cumulating to about 10% in university students
(40). The relatively high prevalence of this condition is likely
to have facilitated etiopathological research in this field and,
consequently, accumulation of established evidence, reviewed in
the current study. At the same time, it is also the most reliable
diagnosis within personality disorders, with superior diagnostic
reliability (Kappa 0.54) compared with other personality
disorders, and similar diagnostic reliability to that observed in
bipolar I disorders (0.56) or schizophrenia (0.46) (41). Given the
severe individual and societal burden and impact of borderline
personality disorder and the limited effect of psychological
interventions (42), knowledge into risk factors associated
with this condition may advance clinical care. The findings
that childhood emotional abuse, emotional/physical neglect,
physical/sexual abuse, and adversities in general emerge as robust
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risk factor for this condition align with multiple salient clinical
features such as affect instability, emotion regulation difficulties,
and maladaptive coping strategies including substance misuse
and frequent self-harm (43, 44). Indeed, it has been suggested
that several core experiences of borderline personality disorders
may be understood as complex post-traumatic stress disorders
(45). The current finding that individuals with a diagnosis of
borderline personality disorders are consistently more likely
to report childhood adversity than non-clinical controls is
consistent with this strong clinical narrative linking childhood
adversity and this condition, and show that evidence survives
several stringent additional criteria making it into class II.
Furthermore, the magnitude of these associations appeared as
very large, with ORs superior to 5 in all cases: emotional
abuse, 28.15; emotional neglect, OR 22.86; adversities, OR 14.32;
physical abuse, OR 9.30; sexual abuse, OR 7.95; physical neglect,
OR 5.73. Although it is important to note that these ORs relate
to case–control studies not surviving prospective analyses, their
large magnitude holds clinical relevance. For example, these
findings indicate that childhood trauma should be systematically
ascertained during the diagnostic assessment of suspected cases
or during their initial clinical management. Notably, these
ORs were not controlled against each other, albeit being likely
correlated. The next generation of research should then develop
a multivariable assessment interview to collect these multiple
exposures in the same individuals assessed for a potential
borderline personality disorder, thus allowing multivariable
association analyses, yet accounting for multicollinearity of
different risk factors. Another future development of research
may involve exploring the transdiagnosticity of childhood
trauma as potential risk factor for other mental disorders such
as eating disorders, depressive disorders, anxiety disorders, and
even psychotic disorders. These considerations are particularly
relevant in the context of potential screening (46) and preventive
interventions (47, 48) and mental health promotion initiatives
(49, 50), because it could potentially be possible to target multiple
outcomes/mental disorders by reducing childhood trauma.
Interestingly, childhood trauma exposure has been linked
with neurobiological modifications in personality disorders,
particularly borderline personality disorder. For example,
variations in volumes of the main brain regions involved in BPD
(especially amygdala and hippocampus) have been associated
to adverse childhood experiences and trauma exposure (51–
54). Also, there is evidence of an association between childhood
trauma and alterations of the cortisol circadian rhythm and
levels, indicating a deregulation of the HPA axis responsiveness,
which could also affect hippocampal volumes (51, 55, 56). Yet,
such alterations are not exclusively present in BPD, as well as
childhood traumatic events are risk factors for other mental
disorders (57), including dependent personality disorder. Hence,
the specific component justifying such a high association between
BPD and childhood adversities remains unknown.
The present work also has several limitations. First, none
of the findings met class I evidence. However, this is due to
the available evidence. Indeed, findings inform the field that
more cohort studies assessing multidimensional risk factors for
personality disorders are needed. Similarly, the lack of evidence
on protective factors is also due to lack of eligible meta-analyses
reporting on protective factors. Second, compared with umbrella
reviews assessing credibility of evidence on risk factors for other
mental or physical disorders (14–17, 58, 59), we included a
limited number of meta-analyses. Again, this indicates that more
research efforts should focus on this clinically relevant field.
Third, despite the large ORs, carefully designed longitudinal
research, including examination of dose–response relationships,
is required before definitive conclusions can be drawn regarding
any causal role played by childhood adversity in the development
of borderline personality disorders.
In conclusion, this umbrella review shows that risk factors
for borderline personality disorder occur during childhood,
and primary prevention strategies should encompass a
multidisciplinary mental health promotion activity going beyond
health professionals, to protect children from any maltreatment,
neglect, or abuse. Risk factors for other personality disorders
have been poorly identified so far, and more longitudinal studies
should be conducted to inform prevention strategies.
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